Waverly Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $708K | Sell |
1,348
-78
| -5% | -$41K | 0.01% | 706 |
|
|
2025
Q1 | $904K | Buy |
1,426
+146
| +11% | +$92.6K | 0.01% | 628 |
|
|
2024
Q4 | $912K | Buy |
1,280
+239
| +23% | +$170K | 0.01% | 537 |
|
|
2024
Q3 | $1.09M | Sell |
1,041
-5
| -0.5% | -$5.26K | 0.02% | 431 |
|
|
2024
Q2 | $1.1M | Buy |
1,046
+8
| +0.8% | +$8.41K | 0.02% | 422 |
|
|
2024
Q1 | $999K | Buy |
1,038
+268
| +35% | +$258K | 0.02% | 368 |
|
|
2023
Q4 | $676K | Sell |
770
-12
| -2% | -$10.5K | 0.03% | 260 |
|
|
2023
Q3 | $644K | Sell |
782
-54
| -6% | -$44.4K | 0.03% | 235 |
|
|
2023
Q2 | $601K | Buy |
+836
| New | +$601K | 0.03% | 226 |
|
|
2017
Q3 | – | Sell |
-431
| Closed | -$212K | – | 236 |
|
|
2017
Q2 | $212K | Buy |
+431
| New | +$212K | 0.05% | 205 |
|
|
2014
Q4 | – | Sell |
-30
| Closed | -$11K | – | 614 |
|
|
2014
Q3 | $11K | Hold |
30
| – | – | 0.01% | 460 |
|
|
2014
Q2 | $8K | Buy |
30
+2
| +7% | +$533 | ﹤0.01% | 496 |
|
|
2014
Q1 | $8K | Buy |
+28
| New | +$8K | ﹤0.01% | 472 |
|